REGULUS THERAPEUTICS INC (RGLS)
Institutional ownership reported to the SEC as of Q2 2025, across 27 quarters.
3
Reporting holders
$408.8K
Reported value
99.8%
Held as options
-68
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| PEAK6 LLC | $408.0K | options only | 0.00% | new | OPTIONS |
| IFP Advisors, Inc | $760 | 0 | 0.00% | new | NEW |
| SIMPLEX TRADING, LLC | $20 | options only | 0.00% | 2q | OPTIONS |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2025 | 3 | $408.8K | 0 | 2 | 0 | 0 | 99.8% |
| Q1 2025 | 71 | $105.5M | 53,550,538 | 14 | 17 | 25 | 0.2% |
| Q4 2024 | 65 | $84.5M | 53,438,132 | 6 | 18 | 13 | 0.0% |
| Q3 2024 | 68 | $86.0M | 54,623,086 | 14 | 17 | 11 | 0.3% |
| Q2 2024 | 62 | $109.3M | 60,982,590 | 24 | 11 | 13 | 0.4% |
| Q1 2024 | 43 | $148.0M | 51,931,549 | 22 | 12 | 4 | 0.8% |
| Q4 2023 | 25 | $14.6M | 11,041,875 | 2 | 4 | 4 | 2.9% |
| Q3 2023 | 23 | $15.3M | 10,808,486 | 1 | 6 | 4 | 3.0% |
| Q2 2023 | 24 | $15.4M | 10,110,955 | 1 | 9 | 2 | 3.3% |
| Q1 2023 | 23 | $8.9M | 10,170,653 | 5 | 2 | 4 | 3.2% |
| Q4 2022 | 20 | $11.8M | 7,950,527 | 4 | 0 | 3 | 7.8% |
| Q3 2022 | 23 | $14.9M | 8,114,036 | 3 | 4 | 3 | 7.6% |
| Q2 2022 | 26 | $13.8M | 6,068,685 | 27 | 0 | 1 | 9.3% |
| Q1 2022 | 39 | $18.3M | 60,661,369 | 3 | 14 | 4 | 1.1% |
| Q4 2021 | 39 | $9.6M | 30,169,407 | 6 | 7 | 9 | 1.0% |
| Q3 2021 | 40 | $16.4M | 22,962,656 | 6 | 7 | 10 | 3.6% |
| Q2 2021 | 44 | $19.5M | 23,064,442 | 11 | 12 | 5 | 3.7% |
| Q1 2021 | 46 | $43.4M | 27,288,565 | 21 | 10 | 6 | 1.9% |
| Q4 2020 | 31 | $25.0M | 18,412,571 | 15 | 7 | 3 | 0.9% |
| Q3 2020 | 23 | $4.0M | 7,813,413 | 3 | 8 | 4 | 0.1% |
| Q2 2020 | 30 | $4.3M | 6,336,080 | 12 | 3 | 5 | 0.0% |
| Q1 2020 | 23 | $4.0M | 8,622,371 | 5 | 4 | 6 | 0.0% |
| Q4 2019 | 19 | $6.4M | 7,218,767 | 1 | 3 | 3 | 0.0% |
| Q3 2019 | 22 | $5.5M | 7,707,004 | 6 | 3 | 3 | 0.0% |
| Q2 2019 | 22 | $12.3M | 9,812,297 | 7 | 5 | 5 | 0.1% |
| Q1 2019 | 24 | $2.7M | 2,656,569 | 8 | 4 | 6 | 0.2% |
| Q4 2018 | 21 | $2.5M | 2,664,887 | 3 | 0 | 0 | 0.4% |